Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
matrix metallopeptidase 1 | 0.385 | 0.885 | 7.7E-18 |
|
disease | 0.900 | limited | 0.875 | 1 | 0 | 2002 | 2019 | ||||||||
|
surfactant protein D | 0.500 | 0.846 | 7.5E-05 |
|
disease | 0.700 | None | 0.917 | 1 | 0 | 2001 | 2019 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
disease | 0.600 | None | 0.979 | 6 | 0 | 2002 | 2019 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
disease | 0.600 | None | 0.911 | 2 | 0 | 1994 | 2020 | ||||||||
|
serpin family A member 1 | 0.410 | 0.923 | 6.8E-08 |
|
disease | 0.500 | None | 0.990 | 1 | 0 | 1977 | 2020 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.400 | None | 0.952 | 5 | 0 | 2000 | 2020 | ||||||||
|
epoxide hydrolase 1 | 0.500 | 0.846 | 3.2E-09 |
|
disease | 0.400 | None | 0.923 | 4 | 0 | 1997 | 2017 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
disease | 0.400 | None | 0.967 | 2 | 0 | 2006 | 2020 | ||||||||
|
elastin | 0.415 | 0.885 | 2.1E-14 |
|
disease | 0.400 | None | 1.000 | 1 | 0 | 2005 | 2019 | ||||||||
|
C-X-C motif chemokine ligand 8 | 0.310 | 0.962 | 2.7E-04 |
|
disease | 0.400 | None | 0.965 | 1 | 0 | 2000 | 2020 | ||||||||
|
nitric oxide synthase 3 | 0.378 | 0.885 | 6.7E-07 |
|
disease | 0.380 | None | 1.000 | 2 | 0 | 2003 | 2015 | ||||||||
|
superoxide dismutase 3 | 0.531 | 0.808 | 7.2E-04 |
|
disease | 0.370 | None | 1.000 | 1 | 0 | 2006 | 2019 | ||||||||
|
cytochrome P450 family 1 subfamily A member 1 | 0.436 | 0.846 | 1.1E-17 |
|
disease | 0.370 | None | 1.000 | 1 | 0 | 2008 | 2019 | ||||||||
|
nitric oxide synthase 2 | 0.364 | 0.923 | 4.0E-15 |
|
disease | 0.350 | None | 0.833 | 2 | 0 | 2003 | 2015 | ||||||||
|
cytochrome P450 family 1 subfamily A member 2 | 0.494 | 0.923 | 2.5E-10 |
|
disease | 0.330 | None | 1.000 | 1 | 0 | 2008 | 2010 | ||||||||
|
troponin T2, cardiac type | 0.601 | 0.423 | 2.0E-03 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2007 | 2008 | ||||||||
|
matrix metallopeptidase 14 | 0.447 | 0.769 | 1.00 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2006 | 2009 | ||||||||
|
CD8a molecule | 0.587 | 0.769 | 1.7E-05 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
disease | 0.300 | None | 0.963 | 2 | 0 | 2003 | 2019 | ||||||||
|
mucin 5AC, oligomeric mucus/gel-forming | 0.483 | 0.808 | 1.0E-08 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2004 | 2020 | ||||||||
|
nuclear factor, erythroid 2 like 2 | 0.357 | 0.885 | 3.6E-03 |
|
disease | 0.300 | None | 0.972 | 1 | 0 | 2008 | 2019 | ||||||||
|
TIMP metallopeptidase inhibitor 1 | 0.380 | 0.885 | 0.50 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2001 | 2019 | ||||||||
|
plasminogen activator, urokinase | 0.425 | 0.923 | 2.3E-06 |
|
disease | 0.230 | None | 1.000 | 1 | 0 | 2005 | 2019 | ||||||||
|
secretory leukocyte peptidase inhibitor | 0.449 | 0.846 | 9.0E-04 |
|
disease | 0.230 | None | 1.000 | 1 | 0 | 2000 | 2020 | ||||||||
|
CF transmembrane conductance regulator | 0.424 | 0.885 | 2.2E-58 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2001 | 2019 |